Treatment of articulatory dysfunction in Parkinson's disease using repetitive transcranial magnetic stimulation

European Journal of Neurology

Volumn 19, Issue 2, 2012, Pages 340-347

  Murdoch, B E ^a   Ng, M L ^b   Barwood, C H S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Dysarthria; Parkinson's disease; Transcranial magnetic stimulation

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FREQUENCY MODULATION; HUMAN; KINEMATICS; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; SHAM PROCEDURE; SPEECH DISORDER; SPEECH INTELLIGIBILITY; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84856040996     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03524.x     Document Type: Article

References (32)

1. Müller J, Wenning GK, Verny M, et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol 2001; 58: 259-264.
2. Ho AK, Bradshaw JL, Iansek R. For better or worse: the effect of levodopa on speech in Parkinson's disease. Mov Disord 2008; 23: 574-580.
3. Krack P. Parkinson's disease: deep brain stimulation. Rev Neurol (Paris) 2002; 158: 135-141.
4. Murdoch BE. Surgical approaches to treatment of Parkinson's disease: implications for speech function. Int J Speech Lang Pathol 2010; 12: 375-384.
5. del Olmo MF, Bello O, Cudeiro J. Transcranial magnetic stimulation over dorsolateral prefrontal cortex in Parkinson's disease. Clin Neurophysiol 2007; 118: 131-139.
6. Ellaway PH, Davey NJ, Maskill DW, Dick JP. The relation between bradykinesia and excitability of the motor cortex assessed using transcranial magnetic stimulation in normal and parkinsonian subjects. Electroencephalogr Clin Neurophysiol 1995; 97: 169-178.
7. Jahanshahi M, Jenkins IH, Brown RG, Marsden CD, Passingham RE, Brooks DJ. Self-initiated versus externally triggered movements. 1. An investigation using measurement of regional cerebral blood flow with PET and movement related potentials in normal and Parkinson's disease subjects. Brain 1995; 118: 913-933.
8. Lomarev MP, Kanchana S, Bara-Jimenez W, Iyer M, Wasserman EM, Hallett M. Placebo-controlled study of rTMS for the treatment of Parkinson's disease. Mov Disord 2006; 21: 325-331.
9. Khedr EM, Rothwell JC, Shawky OA, Ahmed MA, Hamdy A. Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease. Mov Disord 2006; 21: 1311-1316.
10. Elahi B, Elahi B, Chen R. Effect of transcranial magnetic stimulation on Parkinson motor function: systematic review of controlled clinical trials. Mov Disord 2009; 24: 357-363.
11. Liotti M, Ramig LO, Vogel D, et al. Hypophonia in Parkinson's disease: neural correlates of voice treatment revealed by PET. Neurology 2003; 60: 432-440.
12. Edwards MJ, Talelli P, Rothwell JC. Clinical applications of transcranial magnetic stimulation in patients with movement disorders. Lancet Neurol 2008; 7: 827-840.
13. Strafella AP, Paus T, Fraraccio M, Dagher A. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of human motor cortex. Brain 2003; 126: 2609-2615.
14. Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 2001; 21: RC157.
15. Dias AE, Barbosa ER, Coracini K, Maia F, Marcolin MA, Fregni F. Effects of repetitive transcranial magnetic stimulation on voice and speech in Parkinson's disease. Acta Neurol Scand 2006; 113: 92-99.
16. Hartelius L, Svantesson P, Hedlund A, Holmberg B, Revesz D, Thorlin T. Short-term effects of repetitive transcranial magnetic stimulation on speech and voice in individuals with Parkinson's disease. Folia Phoniatr Logop 2010; 62: 104-109.
17. Hughes AJ, Daniel SE, Kliford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
18. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation June 5-7 1996. Electroencephalogr Clin Neurophysiol 1998; 108: 1-16.
19. Siebner HR, Rossmeier C, Mentschel C, Peinemann A, Conrad B. Short-term motor improvement after sub-threshold 5Hz repetitive transcranial magnetic stimulation of the primary motor hand area in Parkinson's disease. J Neurol Sci 2000; 178: 91-94.
20. Filipović SR, Rothwell JC, van de Warrenburg BP, Bhatia K. Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease. Mov Disord 2009; 24: 246-253.
21. Pascual-Leone A, Cohen LG, Brasil-Neto JP, Hallett M. Non-invasive differentiation of motor cortical representation of hand muscles by mapping of optimal current directions. Electroencephalogr Clin Neurophysiol 1994; 93: 42-48.
22. Rödel RMW, Laskawi R, Markus H. Tongue representation in the lateral cortical motor region of the human brain as assessed by transcranial magnetic stimulation. Ann Otol Rhinol Laryngol 2003; 112: 71-76.
23. Rossini PM, Barker AT, Berardelli A, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 1994; 91: 79-92.
24. Yorkston KM, Beukelman DR. Assessment of Intelligibility of Dysarthric speech. Austin, TX: Pro-ed, 1984.
25. Chen Y-T, Murdoch BE, Goozée JV. Electromagnetic articulographic assessment of tongue function in dysarthric and nondysarthric speakers following stroke. J Med Speech Lang Pathol 2008; 16: 21-32.
26. Khedr EM, Farweez HM, Islam H. Therapeutic effect of repetitive transcranial magnetic stimulation on motor function in Parkinson's disease patients. Eur J Neurol 2003; 10: 567-572.
27. Hamada M, Ugawa Y, Tsuji S. High-frequency rTMS over the supplementary motor area for treatment of Parkinson's disease. Mov Disord 2008; 23: 1524-1531.
28. Darley F, Aronson A, Brown J. Motor Speech Disorders. Philadelphia, PA: WB Saunders, 1975.
29. Gangitano M, Valero-Cabre A, Tormos JM, Mottaghy FM, Romero JR, Pascual-Leone A. Modulation of input-output curves by low and high frequency repetitive transcranial magnetic stimulation of the motor cortex. Clin Neurophysiol 2002; 113: 1249-1257.
30. Maeda F, Keenan JP, Tormos JM, Topka H, Pascual-Leone A. Modulation of corticospinal excitability by repetitive transcranial magnetic stimulation. Clin Neurophysiol 2000; 111: 800-805.
31. Khedr EM, Rothwell JC, Shawky OA, Ahmed MA, Foly N, Hamdy A. Dopamine levels after repetitive transcranial magnetic stimulation of motor cortex in patients with Parkinson's disease: preliminary results. Mov Disord 2007; 22: 1046-1050.
32. Rothkegel H, Sommer M, Paulus W. Breaks during 5Hz rTMS are essential for facilitatory after effects. Clin Neurophysiol 2010; 121: 426-430.